Context Therapeutics Reports First Quarter 2023 Operating and Financial Results

Go back to Context Therapeutics Reports First Quarter 2023 Operating and Financial Results
(NASDAQ: CNTX) Delayed: 0.60 -0.01 (1.64%)
Previous Close $0.61    52 Week High
Open $0.60    52 Week Low
Day High $0.61    P/E N/A 
Day Low $0.58    EPS
Volume 964,899